Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy

Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation – Real-world data from the prospective multicentre DEGUM study

(2023) Barbara Meitner-Schellhaas et al.   CLINICAL HEMORHEOLOGY AND MICROCIRCULATION

Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results

(2022) Ernst Michael Jung et al.   CLINICAL HEMORHEOLOGY AND MICROCIRCULATION

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†

(2022) A. Cervantes et al.   ANNALS OF ONCOLOGY

Contrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox®

(2021) Isabel Wiesinger et al.   CLINICAL HEMORHEOLOGY AND MICROCIRCULATION

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial

(2020) Wentao Tang et al.   JOURNAL OF CLINICAL ONCOLOGY

Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS

(2020) Christoph F. Dietrich et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy

(2019) Michael Linecker et al.   JOURNAL OF SURGICAL ONCOLOGY

Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases

(2018) Wujian Mao et al.   Abdominal Radiology

Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis

(2018) Mengxia Yuan et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology

(2017) Severin Huf et al.   ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases

(2017) François Tranquart et al.   ULTRASCHALL IN DER MEDIZIN

Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors

(2016) Wen-Tao Kong et al.   Gut and Liver

High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection

(2016) Zhenhai Lu et al.   MEDICAL ONCOLOGY

Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55

(2016) C. Hackl et al.   ULTRASCHALL IN DER MEDIZIN

Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases

(2015) He-Yue Liang et al.   EUROPEAN RADIOLOGY

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

(2014) T. Gruenberger et al.   ANNALS OF ONCOLOGY

Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer

(2014) Robert P. Jones et al.   EUROPEAN JOURNAL OF CANCER

Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer

(2014) Yiqun Sun et al.   PLoS One

Cancer incidence and mortality in France over the 1980–2012 period: Solid tumors

(2014) F. Binder-Foucard et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE

Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients WithKRASWild-Type Unresectable Colorectal Liver-Limited Metastases

(2013) Le-Chi Ye et al.   JOURNAL OF CLINICAL ONCOLOGY

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

(2012) S De Bruyne et al.   BRITISH JOURNAL OF CANCER

Diffusion-weighted MRI in rectal cancer: Apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness

(2012) Luís Curvo-Semedo et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus

(2012) R. Adam et al.   ONCOLOGIST

An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion

(2012) C. Dietrich et al.   ULTRASCHALL IN DER MEDIZIN

Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: Evaluation of the hemodynamic features and correlation with the chemotherapy response

(2011) Ijin Joo et al.   EUROPEAN JOURNAL OF RADIOLOGY

Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern—Correlation with Clinicopathologic Findings

(2011) Sun Ah Kim et al.   RADIOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER